Awa, Stewie B.

HRN: 20-92-60  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/18/2022
05/24/2022
IV
400mg
Q6h
PCAP C With HRAD
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: